213 related articles for article (PubMed ID: 21909054)
1. Further characterization of ocular safety profile of commercially available preserved and preservative-free triamcinolone acetonide.
Li Y; Chen H; Hou J; Zhang Y; Li G; Gu X; Luo L; Shen H; Qu J; Cheng L
Retina; 2012 Feb; 32(2):364-74. PubMed ID: 21909054
[TBL] [Abstract][Full Text] [Related]
2. [Characteristic of ocular safety profile of triamcinolone made in China].
Lan B; Hou J; Zhao C; Sun S; Li J; Cheng L
Zhonghua Yan Ke Za Zhi; 2014 Jul; 50(7):529-35. PubMed ID: 25312463
[TBL] [Abstract][Full Text] [Related]
3. Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes.
Albini TA; Abd-El-Barr MM; Carvounis PE; Iyer MN; Lakhanpal RR; Pennesi ME; Chevez-Barrios P; Wu SM; Holz ER
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):390-5. PubMed ID: 17197559
[TBL] [Abstract][Full Text] [Related]
4. Preservative-free triamcinolone acetonide injectable suspension versus "traditional" triamcinolone preparations: impact of aggregate size on retinal biocompatibility.
Spitzer MS; Mlynczak T; Schultheiss M; Rinker K; Yoeruek E; Petermeier K; Januschowski K; Szurman P
Retina; 2011 Nov; 31(10):2050-7. PubMed ID: 21747324
[TBL] [Abstract][Full Text] [Related]
5. Retinal toxicity of intravitreal kenalog in albino rabbits.
Lang Y; Zemel E; Miller B; Perlman I
Retina; 2007; 27(6):778-88. PubMed ID: 17621190
[TBL] [Abstract][Full Text] [Related]
6. In vitro benzyl alcohol cytotoxicity: implications for intravitreal use of triamcinolone acetonide.
Chang YS; Wu CL; Tseng SH; Kuo PY; Tseng SY
Exp Eye Res; 2008 Jun; 86(6):942-50. PubMed ID: 18420195
[TBL] [Abstract][Full Text] [Related]
7. [Preservative-free triamcinolone versus purified triamcinolone preparations].
Spitzer MS; Ziemssen F; Yörük E; Bartz-Schmidt KU; Schultheiss M; Szurman P
Klin Monbl Augenheilkd; 2011 Jul; 228(7):626-30. PubMed ID: 21117016
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying benzyl alcohol cytotoxicity (triamcinolone acetonide preservative) in human retinal pigment epithelial cells.
Chang YS; Lin CF; Wu CL; Kuo PY; Wu FS; Shieh CC; Gean PW; Chen ST; Chen MS; Wu WC; Tai MH; Tseng SH
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4214-22. PubMed ID: 21345998
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of triamcinolone acetonide on human retinal pigment epithelial cells.
Chang YS; Wu CL; Tseng SH; Kuo PY; Tseng SY
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2792-8. PubMed ID: 17525214
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal injection of triamcinolone acetonide into healthy rabbit eyes alters retinal function and morphology.
Myers AC; Bruun A; Ghosh F; Adrian ML; Andréasson S; Ponjavic V
Curr Eye Res; 2013 Jun; 38(6):649-61. PubMed ID: 23537282
[TBL] [Abstract][Full Text] [Related]
11. Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.
Kivilcim M; Peyman GA; El-Dessouky ES; Kazi AA; Cheema R; Hegazy H
Ophthalmic Surg Lasers; 2000; 31(6):474-8. PubMed ID: 11095124
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the differences in pharmacokinetics and pharmacodynamics between four distinct formulations of triamcinolone acetonide.
Zacharias LC; Lin T; Migon R; Ghosn C; Orilla W; Feldmann B; Ruiz G; Li Y; Burke J; Kuppermann BD
Retina; 2013 Mar; 33(3):522-31. PubMed ID: 22990317
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits.
Morrison VL; Koh HJ; Cheng L; Bessho K; Davidson MC; Freeman WR
Retina; 2006 Mar; 26(3):339-44. PubMed ID: 16508436
[TBL] [Abstract][Full Text] [Related]
14. Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration.
Kim H; Csaky KG; Gravlin L; Yuan P; Lutz RJ; Bungay PM; Tansey G; DE Monasterio F; Potti GK; Grimes G; Robinson MR
Retina; 2006; 26(5):523-30. PubMed ID: 16770258
[TBL] [Abstract][Full Text] [Related]
15. Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit.
Ruiz-Moreno JM; Montero JA; Bayon A; Rueda J; Vidal M
Exp Eye Res; 2007 Feb; 84(2):342-8. PubMed ID: 17141760
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells.
Narayanan R; Mungcal JK; Kenney MC; Seigel GM; Kuppermann BD
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):722-8. PubMed ID: 16431973
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of intravitreal kenalog toxicity in humans.
Lang Y; Leibu R; Shoham N; Miller B; Perlman I
Ophthalmology; 2007 Apr; 114(4):724-31. PubMed ID: 17224183
[TBL] [Abstract][Full Text] [Related]
18. Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina.
Dierks D; Lei B; Zhang K; Hainsworth DP
Arch Ophthalmol; 2005 Nov; 123(11):1563-9. PubMed ID: 16286619
[TBL] [Abstract][Full Text] [Related]
19. Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes.
Yi NY; Davis JL; Salmon JH; Gilger BC
Vet Ophthalmol; 2008 Sep; 11 Suppl 1():15-9. PubMed ID: 19046265
[TBL] [Abstract][Full Text] [Related]
20. Re: intravitreal toxicity of the Kenalog vehicle (benzyl alcohol) in rabbits.
Carrero JL; Barcia MG; Flores IP
Retina; 2006; 26(9):1100. PubMed ID: 17151509
[No Abstract] [Full Text] [Related]
[Next] [New Search]
